Facioscapulohumeral Muscular Dystrophy (FSHD) is a rare inherited neuromuscular disorder characterized by progressive skeletal muscle weakness and wasting. The disease predominantly affects muscles of the face, shoulders, upper arms, trunk,
Facioscapulohumeral Muscular Dystrophy Clinical Trial Pipeline Accelerates as 10+ Pharma Companies Rigorously Develop Drugs for Market Entry
The Key Neuroendocrine Carcinoma Companies in the market include – Amgen, Chugai Pharmaceutical, AstraZeneca, Pharma Mar, Jazz Pharmaceuticals, Nippon Kayaku, Daiichi Sankyo, Merck, Zai Lab Limited, GSK, Pfizer, Boehringer Ingelheim,
The Key Migraine Companies in the market include – Impel NeuroPharma, Satsuma Pharmaceuticals, Amneal Pharmaceuticals, Axsome Therapeutics, Dr. Reddy’s Laboratories, Tonix Pharmaceuticals, Avanir Pharmaceuticals, Currax Pharmaceuticals, and others. (Albany, US),
The Key Peripheral T-Cell Lymphoma Companies in the market include – Pfizer, Kyowa Kirin, Citius Pharmaceuticals, Secura Bio, Shanghai YingLi Pharmaceutical, Dizal Pharmaceutical, Corvus Pharmaceuticals, and others. (Albany, US), October
The Key Schizophrenia Companies in the market include – Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva
Hong Kong-based consultancy Private Aviation Technology Ltd. (PATL) says leadership team member Ray Wilson, an IS-BAO Stage 3 auditor with
The government-licensed travel agency and private aviation consultancy sent its L’VOYAGE and Private Aviation Technology Ltd. teams to Japan Aviation
(Albany, New York) – October 19, 2026: As per DelveInsight’s assessment, globally, Diabetic Foot Ulcers pipeline constitutes 20+ key companies
The market dynamics for Anal Cancer are expected to witness significant growth, driven by the increasing disease burden, evolving treatment
The market dynamics for Gastroparesis are expected to witness significant growth driven by the rising disease burden, increasing awareness and
